Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results